{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:47:32Z","timestamp":1791557252679,"version":"4.3.4"},"reference-count":122,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive aspergillosis (IA) is the most serious life-threatening infectious complication of intensive remission induction chemotherapy and allogeneic stem cell transplantation in patients with a variety of hematological malignancies. Aspergillus fumigatus is the most commonly isolated species from cases of IA. Despite the various improvements that have been made with preventative strategies and the development of antifungal drugs, there is an urgent need for new therapeutic approaches that focus on strategies to boost the host\u2019s immune response, since immunological recovery is recognized as being the major determinant of the outcome of IA. Here, we aim to summarize current knowledge about a broad variety of immunotherapeutic approaches against IA, including therapies based on the transfer of distinct immune cell populations, and the administration of cytokines and antibodies.<\/jats:p>","DOI":"10.3390\/jof4040137","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T04:44:42Z","timestamp":1544762682000},"page":"137","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Immunomodulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives"],"prefix":"10.3390","volume":"4","author":[{"given":"Chris D.","family":"Lauruschkat","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, University Hospital Wuerzburg, W\u00dc4i, Building C11, 97080 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, University Hospital Wuerzburg, W\u00dc4i, Building C11, 97080 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Loeffler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, University Hospital Wuerzburg, W\u00dc4i, Building C11, 97080 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit. Care"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Filler, S.G., and Sheppard, D.C. (2006). Fungal invasion of normally non-phagocytic host cells. PLoS Pathog., 2.","DOI":"10.1371\/journal.ppat.0020129"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/JCM.00411-17","article-title":"Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs Directly from Plasma Samples","volume":"55","author":"White","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/QCO.0000000000000381","article-title":"Immune responses to invasive aspergillosis: New understanding and therapeutic opportunities","volume":"30","author":"Hohl","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nature08264","article-title":"Surface hydrophobin prevents immune recognition of airborne fungal spores","volume":"460","author":"Aimanianda","year":"2009","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bidula, S., and Schelenz, S. (2016). A Sweet Response to a Sour Situation: The Role of Soluble Pattern Recognition Receptors in the Innate Immune Response to Invasive Aspergillus fumigatus Infections. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005637"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Garth, J.M., Reeder, K.M., Godwin, M.S., Mackel, J.J., Dunaway, C.W., Blackburn, J.P., and Steele, C. (2017). IL-33 Signaling Regulates Innate IL-17A and IL-22 Production via Suppression of Prostaglandin E2 during Lung Fungal Infection. J. Immunol.","DOI":"10.4049\/jimmunol.1602186"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fmicb.2016.00272","article-title":"First line of defense: Innate cell-mediated control of pulmonary aspergillosis","volume":"7","author":"Espinosa","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Khanna, N., Stuehler, C., L\u00fcnemann, A., W\u00f3jtowicz, A., Bochud, P.Y., and Leibundgut-Landmann, S. (2016). Host response to fungal infections\u2014How immunology and host genetics could help to identify and treat patients at risk. Swiss Med. Wkly., 146.","DOI":"10.4414\/smw.2016.14350"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Heinz, W.J., Vehreschild, J.J., and Buchheidt, D. (2018). Diagnostic workout to assess early response indicators in invasive pulmonary aspergillosis in adult patients with hematologic malignancies. Mycoses.","DOI":"10.1111\/myc.12860"},{"key":"ref_11","first-page":"1115","article-title":"Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: Critical appraisal","volume":"19","author":"Leroux","year":"2013","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri2532","article-title":"Intravascular immunity: The host-pathogen encounter in blood vessels","volume":"9","author":"Hickey","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2005.05397.x","article-title":"The immune response to fungal infections","volume":"129","author":"Shoham","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1046\/j.1537-2995.2002.00249.x","article-title":"Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: A comparative analysis of feasibility and outcome for community donors versus related donors","volume":"42","author":"Hubel","year":"2002","journal-title":"Transfusion"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V95.11.3302.010k35_3302_3309","article-title":"Phase I\/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation","volume":"95","author":"Price","year":"2000","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00277-005-1055-z","article-title":"Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia","volume":"84","author":"Mousset","year":"2005","journal-title":"Ann. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2002-05-1552","article-title":"Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation","volume":"100","author":"BitMansour","year":"2002","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2004-07-2676","article-title":"Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia","volume":"105","author":"BitMansour","year":"2005","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4161\/viru.22295","article-title":"The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans)","volume":"3","author":"Means","year":"2012","journal-title":"Virulence"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fmicb.2015.00429","article-title":"Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?","volume":"6","author":"Thakur","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.celrep.2015.08.030","article-title":"CD103(+) Dendritic Cells Control Th17 Cell Function in the Lung","volume":"12","author":"Zelante","year":"2015","journal-title":"Cell Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S1286-4579(02)00007-2","article-title":"Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants","volume":"4","author":"Bozza","year":"2002","journal-title":"Microbes Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1182\/blood-2003-03-0748","article-title":"A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation","volume":"102","author":"Bozza","year":"2003","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/B:VERC.0000046743.27552.19","article-title":"DNA fragment encoding human IL-1beta 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease","volume":"29","author":"Shao","year":"2005","journal-title":"Vet. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.2007.03544.x","article-title":"Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses","volume":"151","author":"Zhu","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.chom.2012.04.005","article-title":"Dendritic cells in antifungal immunity and vaccine design","volume":"11","author":"Roy","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.imbio.2012.10.013","article-title":"Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity","volume":"218","author":"Schmidt","year":"2013","journal-title":"Immunobiology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3389\/fimmu.2017.01623","article-title":"Natural Killer Cells in Antifungal Immunity","volume":"8","author":"Schmidt","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1038\/s41598-017-06238-4","article-title":"CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells","volume":"7","author":"Ziegler","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/infdis\/jiq062","article-title":"Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia","volume":"203","author":"Schmidt","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/infdis\/jiv143","article-title":"Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis","volume":"212","author":"Stuehler","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.0803462","article-title":"Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis","volume":"182","author":"Park","year":"2009","journal-title":"J. Immunol."},{"key":"ref_37","first-page":"339","article-title":"Interleukin-2 and increased natural killer activity in mice experimentally infected with Aspergillus niger","volume":"11","author":"Benedetto","year":"1988","journal-title":"Microbiologica"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jcyt.2013.06.017","article-title":"Treatment of patients with advanced cancer with the natural killer cell line NK-92","volume":"15","author":"Tonn","year":"2013","journal-title":"Cytotherapy"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14653240802301872","article-title":"Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: A phase I trial","volume":"10","author":"Arai","year":"2008","journal-title":"Cytotherapy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jcyt.2017.07.008","article-title":"Phase 1 clinical trial of adoptive immunotherapy using \u201coff-the-shelf\u201d activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia","volume":"19","author":"Boyiadzis","year":"2017","journal-title":"Cytotherapy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1537-2995.2012.03764.x","article-title":"Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions","volume":"53","author":"Klingemann","year":"2013","journal-title":"Transfusion"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14570","article-title":"Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma","volume":"177","author":"Shah","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Dewi, I., van de Veerdonk, F., and Gresnigt, M. (2017). The Multifaceted Role of T-Helper Responses in Host Defense against Aspergillus fumigatus. J. Fungi.","DOI":"10.3390\/jof3040055"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2015.10.005","article-title":"Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges","volume":"98","author":"Papadopoulou","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/bmt.2008.271","article-title":"Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy","volume":"43","author":"Tramsen","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcyt.2012.11.014","article-title":"Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes","volume":"15","author":"Tramsen","year":"2013","journal-title":"Cytotherapy"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2010-12-322610","article-title":"Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154","volume":"118","author":"Khanna","year":"2011","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/infdis\/jiu607","article-title":"Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections","volume":"211","author":"Stuehler","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jcyt.2015.05.011","article-title":"Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer","volume":"17","author":"Bacher","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1128\/IAI.01700-14","article-title":"Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells","volume":"82","author":"Tramsen","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.it.2012.04.008","article-title":"From memory to antifungal vaccine design","volume":"33","author":"Iannitti","year":"2012","journal-title":"Trends Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1537","article-title":"Advances in combating fungal diseases: Vaccines on the threshold","volume":"5","author":"Cutler","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1007\/s10096-012-1670-2","article-title":"Adoptive immunity mediated by HLA-A*0201 restricted Asp f16 peptides-specific CD8+ T cells against Aspergillus fumigatus infection","volume":"31","author":"Sun","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41577-018-0042-2","article-title":"CAR T cells for infection, autoimmunity and allotransplantation","volume":"18","author":"Maldini","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.drudis.2018.02.012","article-title":"Approved CAR T cell therapies: Ice bucket challenges on glaring safety risks and long-term impacts","volume":"23","author":"Zheng","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/cr.2016.154","article-title":"Driving gene-engineered T cell immunotherapy of cancer","volume":"27","author":"Johnson","year":"2017","journal-title":"Cell Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/imr.12131","article-title":"Design and development of therapies using chimeric antigen receptor-expressing T cells","volume":"257","author":"Dotti","year":"2014","journal-title":"Immunol. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3389\/fimmu.2017.01939","article-title":"Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells","volume":"8","author":"Kumaresan","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.4049\/jimmunol.0901766","article-title":"The optimal antigen response of chimeric antigen receptors harboring the CD3zeta transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR\/CD3 complex","volume":"184","author":"Bridgeman","year":"2010","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.immuni.2016.02.001","article-title":"Costimulation Engages the Gear in Driving CARs","volume":"44","author":"Abken","year":"2016","journal-title":"Immunity"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1158\/0008-5472.CAN-07-5600","article-title":"Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system","volume":"68","author":"Singh","year":"2008","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7517350","DOI":"10.1155\/2017\/7517350","article-title":"Granulocyte Colony-Stimulating Factor and Its Potential Application for Skeletal Muscle Repair and Regeneration","volume":"2017","author":"Wright","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.2005.05.645","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia: A meta-analysis of randomized controlled trials","volume":"23","author":"Clark","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dki252","article-title":"Experimental systemic murine aspergillosis: Treatment with polyene and caspofungin combination and G-CSF","volume":"56","author":"Sionov","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/513961","article-title":"Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens","volume":"175","author":"Liles","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1200\/JCO.2004.06.102","article-title":"Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: A study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"22","author":"Ringden","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2011-09-379214","article-title":"Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling","volume":"119","author":"Hume","year":"2012","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood.V82.5.1422.1422","article-title":"Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor","volume":"82","author":"Nemunaitis","year":"1993","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1084\/jem.20151975","article-title":"M-CSF improves protection against bacterial and fungal infections after hematopoietic stem\/progenitor cell transplantation","volume":"213","author":"Kandalla","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/cyto.2001.0889","article-title":"Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus","volume":"15","author":"Gonzalez","year":"2001","journal-title":"Cytokine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"568543","DOI":"10.1155\/2015\/568543","article-title":"Pivotal roles of GM-CSF in autoimmunity and inflammation","volume":"2015","author":"Shiomi","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mib.2017.10.018","article-title":"Modulating host immune responses to fight invasive fungal infections","volume":"40","author":"Scriven","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/clinids\/12.1.41","article-title":"Granulocyte-macrophage colony-stimulating factor: Pleiotropic cytokine with potential clinical usefulness","volume":"12","author":"Ruef","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial","volume":"33","author":"Wan","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000342121","article-title":"Granulocyte macrophage colony-stimulating factor in 66 patients with myeloid or lymphoid neoplasms and recipients of hematopoietic stem cell transplantation with invasive fungal disease","volume":"129","author":"Safdar","year":"2013","journal-title":"Acta Haematol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1189\/jlb.70.6.868","article-title":"In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages","volume":"70","author":"Brummer","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.00760-07","article-title":"Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis","volume":"52","author":"Quezada","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/368383","article-title":"Regulation by granulocyte-macrophage colony-stimulating factor and\/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia","volume":"187","author":"Brummer","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1086\/314493","article-title":"Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis","volume":"178","author":"Cenci","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/IAI.69.3.1554-1560.2001","article-title":"Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus","volume":"69","author":"Brieland","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2567.2009.03211.x","article-title":"Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity","volume":"130","author":"Chai","year":"2010","journal-title":"Immunology"},{"key":"ref_86","first-page":"493758","article-title":"Invasive aspergillosis in a renal transplant recipient successfully treated with interferon-gamma","volume":"2012","author":"Estrada","year":"2012","journal-title":"Case Rep. Transplant."},{"key":"ref_87","first-page":"1359","article-title":"Interferon gamma in association with immunosuppressive drugs withdrawal and antifungal combination as a rescue therapy for cerebral invasive Aspergillosis in a liver transplant recipient","volume":"80","author":"Mezidi","year":"2014","journal-title":"Minerva Anestesiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1099\/0022-1317-51-1-70","article-title":"Massive intracerebral aspergillosis responding to combination high dose liposomal amphotericin B and cytokine therapy without surgery","volume":"51","author":"Ellis","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1183\/09031936.06.00021705","article-title":"Interferon-gamma therapy in two patients with progressive chronic pulmonary aspergillosis","volume":"27","author":"Kelleher","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"The International Chronic Granulomatous Disease Cooperative Study Group (1991). A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N. Engl. J. Med., 324, 509\u2013516.","DOI":"10.1056\/NEJM199102213240801"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/j.1600-6143.2010.03094.x","article-title":"Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients","volume":"10","author":"Teo","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Delsing, C.E., Gresnigt, M.S., Leentjens, J., Preijers, F., Frager, F.A., Kox, M., Monneret, G., Venet, F., Bleeker-Rovers, C.P., and van de Veerdonk, F.L. (2014). Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: A case series. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-166"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s15010-008-7378-7","article-title":"Interferon-gamma and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis","volume":"36","author":"Bandera","year":"2008","journal-title":"Infection"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/13693780412331271072","article-title":"Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: Comparison with Aspergillus spp.","volume":"43","author":"Winn","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1086\/314679","article-title":"Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens","volume":"179","author":"Gaviria","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/cncr.20883","article-title":"The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation","volume":"103","author":"Safdar","year":"2005","journal-title":"Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humimm.2006.10.011","article-title":"Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis","volume":"68","author":"Sainz","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1128\/IAI.66.12.5999-6003.1998","article-title":"Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus","volume":"66","author":"Roilides","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","article-title":"Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis","volume":"172","author":"Nagai","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4049\/jimmunol.162.3.1633","article-title":"Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis","volume":"162","author":"Mehrad","year":"1999","journal-title":"J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"739","DOI":"10.18632\/oncotarget.344","article-title":"Systemic use of tumor necrosis factor alpha as an anticancer agent","volume":"2","author":"Roberts","year":"2011","journal-title":"Oncotarget"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2217\/imt.12.127","article-title":"Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections","volume":"4","author":"Pikman","year":"2012","journal-title":"Immunotherapy"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mib.2012.04.004","article-title":"Recent progress in vaccines against fungal diseases","volume":"15","author":"Cassone","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/342509","article-title":"Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis","volume":"186","author":"Ito","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/jmm.0.033290-0","article-title":"Saccharomyces as a vaccine against systemic aspergillosis: \u2018the friend of man\u2019 a friend again?","volume":"60","author":"Liu","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.165.1.381","article-title":"T cell vaccination in mice with invasive pulmonary aspergillosis","volume":"165","author":"Cenci","year":"2000","journal-title":"J. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1128\/IAI.00815-06","article-title":"Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis","volume":"74","author":"Ito","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.0900961","article-title":"Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination","volume":"183","author":"Bozza","year":"2009","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3109\/13693786.2012.683539","article-title":"Vaccination with mannan protects mice against systemic aspergillosis","volume":"50","author":"Liu","year":"2012","journal-title":"Med. Mycol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","article-title":"Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases","volume":"11","author":"Casadevall","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1093\/cid\/civ269","article-title":"Good syndrome: An adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications","volume":"61","author":"Malphettes","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000369493","article-title":"Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation","volume":"7","author":"Braem","year":"2015","journal-title":"J. Innate Immun."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Torosantucci, A., Chiani, P., Bromuro, C., De Bernardis, F., Palma, A.S., Liu, Y., Mignogna, G., Maras, B., Colone, M., and Stringaro, A. (2009). Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005392"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/IAI.70.5.2375-2382.2002","article-title":"Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation","volume":"70","author":"Cenci","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_117","first-page":"283","article-title":"Radioimmunotherapy of fungal diseases: The therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens","volume":"2","author":"Nosanchuk","year":"2011","journal-title":"Front. Microbiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.ymthe.2017.06.012","article-title":"Engineering Natural Killer Cells for Cancer Immunotherapy","volume":"25","author":"Rezvani","year":"2017","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S1470-2045(17)30852-5","article-title":"Checkpoint inhibitors and aspergillosis in AML: The double hit hypothesis","volume":"18","author":"Daver","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Fites, J.S., Gui, M., Kernien, J.F., Negoro, P., Dagher, Z., Sykes, D.B., Nett, J.E., Mansour, M.K., and Klein, B.S. (2018). An unappreciated role for neutrophil-DC hybrids in immunity to invasive fungal infections. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007073"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cmdc.201600236","article-title":"Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity","volume":"11","author":"Ngo","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/21505594.2016.1196301","article-title":"Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi","volume":"8","author":"Wiederhold","year":"2017","journal-title":"Virulence"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/4\/137\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:33:54Z","timestamp":1760196834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/4\/137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":122,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["jof4040137"],"URL":"https:\/\/doi.org\/10.3390\/jof4040137","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]}}}